NEU 2.90% $19.86 neuren pharmaceuticals limited

autism, retts and nnz-2566, page-2

  1. 35,698 Posts.
    lightbulb Created with Sketch. 552
    You only have to look at the Board for Autism Speaks that says that $38.7M push towards finidng drugs to treat Autism is only the tip of the iceberg - while no doubt Roche is what first appears the headline being in the top 5 big pharma globally the board of Autism Speaks is linked to probably the biggest source off cash anywhere with many high profile appointments to the board mainly as a result of their children having Autism, it goes to show the power out there to reach a soultion. If the science is there I think the money will be right behind it.

    Autism Speaks Board

    Curtis Arledge
    CEO - BNY Mellon (with $27 Trillion in assets under management)

    Adrian M. Jones
    Managing Director - Goldman Sachs

    T. Michael Glenn
    Exec. Vice President - FedEx Corporation

    Bernie Marcus
    CoFounder - The Home Depot






 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.